113 related articles for article (PubMed ID: 27498705)
1. Identification of brefelamide as a novel inhibitor of osteopontin that suppresses invasion of A549 lung cancer cells.
Zhang J; Yamada O; Kida S; Matsushita Y; Murase S; Hattori T; Kubohara Y; Kikuchi H; Oshima Y
Oncol Rep; 2016 Oct; 36(4):2357-64. PubMed ID: 27498705
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of osteopontin mediates a novel mechanism underlying the cytostatic activity of TGF-β.
Zhang J; Yamada O; Kida S; Matsushita Y; Hattori T
Cell Oncol (Dordr); 2016 Apr; 39(2):119-28. PubMed ID: 26584547
[TBL] [Abstract][Full Text] [Related]
3. Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.
Kang CG; Im E; Lee HJ; Lee EO
Bioorg Med Chem Lett; 2017 May; 27(9):1914-1918. PubMed ID: 28359791
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin knockdown suppresses non-small cell lung cancer cell invasion and metastasis.
Sun BS; You J; Li Y; Zhang ZF; Wang CL
Chin Med J (Engl); 2013; 126(9):1683-8. PubMed ID: 23652051
[TBL] [Abstract][Full Text] [Related]
5. Osteopontin as a potential biomarker of proliferation and invasiveness for lung cancer.
Zhao B; Sun T; Meng F; Qu A; Li C; Shen H; Jin Y; Li W
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1061-70. PubMed ID: 21207061
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of p90 ribosomal S6 kinase attenuates cell migration and proliferation of the human lung adenocarcinoma through phospho-GSK-3β and osteopontin.
Abdulrahman N; Jaballah M; Poomakkoth N; Riaz S; Abdelaziz S; Issa A; Mraiche F
Mol Cell Biochem; 2016 Jul; 418(1-2):21-9. PubMed ID: 27236820
[TBL] [Abstract][Full Text] [Related]
7. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
[TBL] [Abstract][Full Text] [Related]
8. Interferon-induced transmembrane 3 binds osteopontin in vitro: expressed in vivo IFITM3 reduced OPN expression.
El-Tanani MK; Jin D; Campbell FC; Johnston PG
Oncogene; 2010 Feb; 29(5):752-62. PubMed ID: 19901966
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin silencing by small interfering RNA induces apoptosis and suppresses invasion in human renal carcinoma Caki-1 cells.
Zhang A; Liu Y; Shen Y; Xu Y; Li X
Med Oncol; 2010 Dec; 27(4):1179-84. PubMed ID: 19921477
[TBL] [Abstract][Full Text] [Related]
10. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
Wang ZM; Cui YH; Li W; Chen SY; Liu TS
Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
[TBL] [Abstract][Full Text] [Related]
12. Rho-associated kinase signaling is required for osteopontin-induced cell invasion through inactivating cofilin in human non-small cell lung cancer cell lines.
Kang CG; Han HJ; Lee HJ; Kim SH; Lee EO
Bioorg Med Chem Lett; 2015 May; 25(9):1956-60. PubMed ID: 25817589
[TBL] [Abstract][Full Text] [Related]
13. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
14. Oct4 upregulates osteopontin via Egr1 and is associated with poor outcome in human lung cancer.
Feng YH; Su YC; Lin SF; Lin PR; Wu CL; Tung CL; Li CF; Shieh GS; Shiau AL
BMC Cancer; 2019 Aug; 19(1):791. PubMed ID: 31399076
[TBL] [Abstract][Full Text] [Related]
15. Influence of osteopontin silencing on survival and migration of lung cancer cells.
Polat B; Wohlleben G; Katzer A; Djuzenova CS; Technau A; Flentje M
Strahlenther Onkol; 2013 Jan; 189(1):62-7. PubMed ID: 23161119
[TBL] [Abstract][Full Text] [Related]
16. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
Du XL; Jiang T; Sheng XG; Gao R; Li QS
Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K.
Liu J; Liu Q; Wan Y; Zhao Z; Yu H; Luo H; Tang Z
Int J Oncol; 2014 Jul; 45(1):282-90. PubMed ID: 24756245
[TBL] [Abstract][Full Text] [Related]
20. The O‑glycosylation mutant osteopontin alters lung cancer cell growth and migration in vitro and in vivo.
Minai-Tehrani A; Chang SH; Park SB; Cho MH
Int J Mol Med; 2013 Nov; 32(5):1137-49. PubMed ID: 24008322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]